Company Filing History:
Years Active: 1987-1990
Title: C John Parli: Innovator in Pharmaceutical Chemistry
Introduction
C John Parli is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of compounds that serve as 5HT receptor antagonists.
Latest Patents
Among his latest patents are the cycloalkanol esters of dihydrolysergic acid. These include cycloalkyl or ketocycloalkyl esters of 1-substituted-6-C.sub.1-4 straight chain alkyl (or allyl)-ergoline-8.beta.-carboxylic acids, which are useful as 5HT receptor antagonists. This innovative work showcases his expertise in creating compounds with potential therapeutic applications.
Career Highlights
C John Parli is currently associated with Eli Lilly and Company, a leading pharmaceutical firm. His role at the company allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His innovative spirit and dedication to advancing medical science are evident in his patent portfolio.
Collaborations
Some of his notable coworkers include Kathleen R Whitten and William L Garbrecht. Their collaborative efforts in research and development have further enhanced the impact of their work in the pharmaceutical field.
Conclusion
C John Parli's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.